According to a new market report published by Persistence Market
Research “Global Market Study on Neurosurgical Products:
AsiaPacific to Witness Highest Growth by 2022”, the global
neurosurgical products market is estimated to be valued at
US$3,685.8Mn by the end of2015 and expand at a CAGR of 11.2% from
2015 to 2022, to account forUS$7,756.2Mn by2022.
The global neurosurgical products market is witnessing significant
growth due to growing geriatric population. Moreover, increasing the
incidence of brain tumors, growing government funding, and rising
awareness about neurosurgical disorders are also driving the growth
of the market. Furthermore, growing demand for minimally invasive
surgeries is expected to create growth opportunities for the
neurosurgical products market over the forecast period. However,
stringent regulatory requirements, long approval times for new
neurosurgical products, and availability of alternative treatment for
neurosurgical diseases inhibit the growth of the market. The
neurosurgical products market is anticipated to grow from an
estimated US$3,685.8 Mn by the end of 2015 to US$7,756.2 Mn by 2022
at a CAGR of 11.2% during the forecast period.
Request to view table of content @
The North America market is growing at a significant rate due to
increasing healthcare expenditure, rising geriatric population, and
increasing the prevalence of brain tumor in the region. According to
the Brain Aneurysm Foundation, approximately 6 million people in the
U.S. have a unruptured brain aneurysm and annually around 30,000
people suffer from brain aneurysm rupture. Moreover, initiatives
taken by various government associations are helping to spread
awareness about advanced neurosurgical products in North America.
In Europe, increasing aging population, high healthcare expenditure,
and increasing awareness about neurological conditions are driving
the growth of the neurosurgical products market. According to the
European Commission, Germany had the highest geriatric population (60
years and above) base among all European Union member states,
accounting for 20.6% of the total population of the country in 2011.
This number is poised to reach approximately 50% by 2030. Moreover,
according to the NHS Commissioning Board in England, the U.K., Great
Britain, neurosurgery is witnessing an annual growth of 2%-5%. With
increasing number of neurosurgical procedures, demand for
neurosurgical products is also poised to rise over the next few
years.
Request Sample Report @
Growth of the neurosurgical products market in Asia-Pacific is
primarily attributed to rising geriatric population, increasing
healthcare expenditure, and growing awareness of the neurological
condition in the region. According to UN reports, 10.1% of the total
population of China is aged 60 years and above and this is expected
to reach 30% by 2050. Moreover, the incidence of brain cancer is also
increasing in the region. According to GLOBOCAN-an international
agency, for research on cancer-5,510 people in Japan suffered from
brain cancer in 2012 and this number is poised to reach 5,960 by
2020.
Integra LifeSciences Holdings Corporation, KARL STORZ GmbH & Co.
KG., Medtronic plc, Johnson & Johnson Services, Inc., Stryker
Corporation, B. Braun Melsungen AG, Terumo Corporation, and Elekta
AB. some of the major players of the neurosurgical products market.
Buy Neurosurgical Products Market Report @
No comments:
Post a Comment